AltaThera Pharmaceuticals

About

AltaThera Pharmaceuticals is a commercial-stage precision medicine company based in Chicago, Illinois. The company specializes in developing and commercializing innovative therapies for critical care patients, particularly those with cardiovascular conditions such as atrial fibrillation (AFib) and severe or rare disorders. Founded as a specialty pharmaceutical firm, AltaThera focuses on patient-centered solutions that leverage innovative science to meet unmet medical needs in hospitalized patients. The company's flagship product is Sotalol IV, an intravenous formulation of the antiarrhythmic agent sotalol. This product allows for faster initiation of therapy for AFib patients and has received FDA approval for new indications to enhance patient outcomes. AltaThera emphasizes a precision medicine approach, aiming to individualize cardiovascular drug treatments based on clinical data analysis. The company primarily serves the healthcare sector, targeting hospitals and critical care providers.